144 ·Filed Jun 15, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001294192-26-000002
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale from RSU vesting with no material signal. Monitor for any acceleration in insider selling or changes in pattern, but no immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
RVMD ▲ +29.87% at T+60d
NEUTRAL call ✓ call won +29.87% · α vs SPY +28.87% · entry $156.58 → $203.35
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
+0.76%
call +0.76% · α +2.01%
$157.77
settled 4mo ago
T+5d
+8.26%
call +8.26% · α +10.49%
$169.51
settled 3mo ago
T+20d
+18.13%
call +18.13% · α +17.93%
$184.97
settled 3mo ago
T+60d
+29.87%
call +29.87% · α +28.87%
$203.35
settled 22d ago

Price Chart

Loading chart...

Executive Summary

Officer Margaret A. Horn filed a Form 144 notice of intent to sell 3,486 shares of Revolution Medicines common stock, valued at approximately $536K. This is a routine sale from vested RSU grants and follows prior sales of 14,583 shares over the past three months. The proposed sale is immaterial relative to the company's $32.7B market cap.

Key Facts

  • Insider: Margaret A. Horn, an officer of Revolution Medicines
  • Proposed sale: 3,486 shares of common stock, estimated value $536,390.82
  • Shares acquired from RSU grants on 03/01/2023, 03/01/2024, and 03/01/2025
  • Prior sales in past 3 months: 4,583 shares on 03/17/2026 and 10,000 shares on 06/11/2026
  • Filing date: June 15, 2026

Financial Impact

Proceeds of ~$536K from sale of 3,486 shares; negligible relative to $32.7B market cap

Risk Factors

  • None material from this filing; insider selling pattern is consistent with RSU vesting and tax obligations

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
96% bullish (27 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001294192-26-000002
Document: 0001294192-26-000002-index.html0001294192-26-000002
Document: 0001294192-26-000002.txt0001294192-26-000002
26 reports for RVMD
Performance horizon
100% Hit rate 12 of 12 directional calls best @ T+60▲ +31.56%Apr 21, 2026
Filters
Rows
Reports for RVMD — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
144
NEUTRAL ★ 2/10
$195.92 $190.74▼ −2.64%▼ −5.21%$206.54 (+5.42%)
Sep 15, 2026
16d ago
144
NEUTRAL ★ 4/10
$195.92 $190.74▼ −2.64%▼ −5.21%$206.54 (+5.42%)
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$204.86 $190.95▼ −6.79%▼ −7.61%$206.54 (+0.82%)
Sep 14, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$204.86 $192.86▼ −5.86%▼ −7.98%$206.54 (+0.82%)
Aug 26, 2026
5w ago
8-K
BULLISH ★ 8/10
$215.44 $209.23▼ −2.88%▼ −2.76%$206.54 (−4.13%)
Aug 26, 2026
5w ago
Press Release
BULLISH ★ 8/10
$215.44 $209.23▼ −2.88%▼ −2.76%$206.54 (−4.13%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$211.38 $209.87▼ −0.71%▼ −0.18%$206.54 (−2.29%)
Jul 2, 2026
13w ago
Press Release
BULLISH ★ 7/10
$189.24 $191.13▲ +1.00%▲ +0.07%$206.54 (+9.14%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$187.51 $190.46▲ +1.57%▲ +1.31%$206.54 (+10.15%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$165.81 $192.62▲ +16.17%▲ +16.62%$206.54 (+24.56%)
Showing 10 of 26

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access